Pelago bioscience AB:1469771 24-004859 bimn unit requires service contract in order to needed for the development of a new assay to test compounds of interest.

Ended Purchase Order Awarded Last action

Contract number
75N95024P00578
Awardee
Awarding agency
Obligated
$24,900

Award facts

Contract value 100% obligated
$24,900.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Baltimore, MD 21224, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.

Quick answers

Who was awarded contract 75N95024P00578?

75N95024P00578 was awarded to Pelago Bioscience AB by National Institute on Drug Abuse (National Institutes of Health) on September 9, 2024.

How much is contract 75N95024P00578 worth?

The government has obligated $24,900 on 75N95024P00578.

Was contract 75N95024P00578 competed?

The extent of competition for 75N95024P00578 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login